<DOC>
	<DOCNO>NCT02050217</DOCNO>
	<brief_summary>Neurally Adjusted Ventilatory Assist ( NAVA ) new form partial support wherein machine applies positive pressure throughout inspiration proportion electrical activity diaphragm ( EAdi ) , Because ventilator function cycle control patient 's respiratory drive rhythm , NAVA potential enhance patient-ventilator interaction ensure synchrony minimize risk over-assistance . Among different interface , pediatric helmet well tolerate facial nasal mask , thus require less sedation allow prolonged ventilatory assistance ( 5-6 ) .To date , data exist use NAVA infant noninvasive ventilation . The aim physiological study compare patient-ventilator interaction infant receive NIV NAVA Pressure Support Ventilation ( PSV ) helmet .</brief_summary>
	<brief_title>NAVA Helmet Pediatric Respiratory Failure</brief_title>
	<detailed_description>Neurally Adjusted Ventilatory Assist ( NAVA ) new form partial support wherein machine applies positive pressure throughout inspiration proportion electrical activity diaphragm ( EAdi ) , assess trans-esophageal electromyography ( 1 ) . Because ventilator function cycle control patient 's respiratory drive rhythm , NAVA potential enhance patient-ventilator interaction ensure synchrony minimize risk over-assistance . A high incidence asynchrony event demonstrate significant clinical impact favour weaning failure long duration mechanical ventilation ( 2 ) . NAVA implement safely animal , healthy volunteer critically ill adult show improve patient-ventilator synchrony , limit excessive airway pressure tidal volume , unload respiratory muscle tracheally intubated patient ( 1,3,4 ) . Moreover NAVA find effective deliver non-invasive ventilation ( NIV ) even interface excessively leaky ( 75 % leak ) reduce positive end-expiratory pressure ( 3 ) . With condition , NAVA able unload respiratory muscle preserve gas exchange , maintain synchrony respiratory demand . Data medical literature group demonstrate pediatric helmet well tolerate facial mask , require less sedation allow prolonged ventilatory assistance due good tolerance ( 5-6 ) . To date , data exist use NAVA infant noninvasive ventilation . The aim physiological study compare patient-ventilator interaction infant receive NIV NAVA Pressure Support Ventilation ( PSV ) . Equipment . NAVA conventional PSV provide Servo-I ventilator ( Maquet Critical Care , Solna , Sweden ) . Electrical activity diaphragm ( EAdi ) obtain use array nine miniaturize electrode ( space 6 mm apart ) mount conventional ( 5.5F ) feeding tube ( Maquet Critical Care AB , Solna , Sweden ; Neurovent Research Inc , Toronto , Canada ) , position low esophagus level diaphragm . Confirmation appropriate placement achieve view online electrical display catheter . The presence good quality EAdi trace p wave display central electrode indicate optimal positioning , array span diaphragm equally caudal cranial direction . A pediatric helmet use interface patient ventilator . Tidal volume , airway pressure flow trace record Servo I NAVA Tracker acquisition system . Experimental protocol . Enrolled patient , stabilization period oxygen therapy standard medical treatment ( antibiotic , steroid , Inhaled beta 2 agonist ) , receive two 60-minutes ventilatory trial deliver pediatric helmet . After baseline trial PSV conventional , child allocate receive 1 trial NAVA NIV 1 trial PSV conventional . The sequence two ventilatory trial randomize accord seal opaque envelops . Ventilatory trial follow : 1 . NAVA-NIV 2 . PSV conventional . The first 15 min period consider wash period patient carefully observe reaction problem occur technique . After first 15 min period , data record study start . NAVA PSV level set attend physician order obtain Tidal Volume ( TV ) 6-8 ml/kg , peripheral oxygen saturation ( SpO2 ) &gt; 94 % , Respiratory Rate ( RR ) &lt; +/-2 SD age . Sedation analgesia provide accord standardized PICU protocol , need change two study window patient . Monitoring .All infant monitor follow : SpO2 , EKG continuously ; arterial blood pressure every 15 min ; arterial blood gas enrolment trial . The total amount drug need sedation and/or complication ( intolerance interface , leak , gastric distension ) also record . Statistics . No data available moment medical literature infant . Based retrospective data adult literature , predict reduction primary end point ( AI ) NAVA versus Conventional flow trigger PSV , around 20 % . The power analysis indicate sample size 12 patient need demonstrate 20 % reduction AI two ventilator mode alfa beta risk 005 0.2 respectively . Sample size calculation perform GPower3.1.2 software ( Kiel University , Germany )</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<criteria>Infants age &gt; 1 month &lt; 2 year ARF ( PaO2/FiO2 &lt; 300 mmHg , accessory muscle recruitment , Respiratory Rate 2 SD related age ) , Intact neuromuscular pathway diaphragm Hemodynamic instability Reduction airway protection Coma Contraindication insert nasogastric catheter Heart and/or lung transplant Increase PIC Refusal parent legal guardian</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Helmet</keyword>
	<keyword>Neurally Adjusted Ventilatory Assist</keyword>
	<keyword>Children</keyword>
	<keyword>Respiratory Failure</keyword>
</DOC>